PREVALENCE OF PERIPHERAL NEUROPATHY IN CHRONIC MUSCULOSKELETAL OEDEMATOUS CONDITIONS
DOI:
https://doi.org/10.15621/ijphy/2019/v6i6/190226Keywords:
Peripheral neuropathy, Oedema, Modified Total Neuropathy Score, VAS, Musculoskeletal AssessmentAbstract
Background: Neuropathic pain is a compound, persistent pain condition that results from illness or damage to the peripheral nervous system, central nervous system, or both. The nerve might get compressed due to various factors but one of the causes is an increase in oncotic pressure of interstitial fluid which may lead to neuropraxia. So, this may lead to symptoms of peripheral neuropathy. The objectives of the study were to determine the prevalence of peripheral neuropathy in chronic musculoskeletal oedematous conditions and to study the association of peripheral neuropathy in chronic musculoskeletal oedematous conditions with demographic variables.
Methods: A total of 52 subjects were assessed and all were included in the study based on inclusion criteria. Peripheral neuropathy was diagnosed using Modified Total Neuropathy Score (mTNS) and pain assessment using Visual Analogue Scale (VAS), oedema assessment and also musculoskeletal assessment was done for assessing the severity of peripheral neuropathy.
Results: Statistical results suggests that the prevalence of peripheral neuropathy in chronic musculoskeletal oedematous conditions having moderate neuropathy symptoms is 0.8445, the prevalence of minor neuropathy symptoms is <0.0001 and moderately severe symptoms is <0.0001. As the maximum population has moderate neuropathy symptoms, the prevalence of peripheral neuropathy in chronic musculoskeletal oedematous conditions is 0.8445.
Conclusion: Among the fifty-two subjects having oedema, twenty-seven subjects had moderate neuropathy symptoms, fourteen subjects had minor neuropathy symptoms and eleven subjects had moderately severe symptoms. Thus, it clarifies that subjects having oedema are likely to get neuropathic symptoms at a later stage.
References
Trayes KP, Studdiford JS, Pickle S, Tully AS. Edema: diagnosis and management. American family physician. 2013 Jul 15;88(2):102-10.
Carpentier PH, Maricq HR, Biro C, Ponçot-Makinen CO, Franco A. Prevalence, risk factors, and clinical patterns of chronic venous disorders of lower limbs: a population-based study in France. Journal of vascular surgery. 2004 Oct 1;40(4):650-9.
Cho S, Atwood JE. Peripheral edema. The American journal of medicine. 2002 Nov 1;113(7):580-6.
Villeco JP. Edema: a silent but important factor. Journal of Hand Therapy. 2012 Apr 1;25(2):153-62.
Mafukidze AT, Calnan M, Furin J. Peripheral neuropathy in persons with tuberculosis. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 2016 Jan 1;2:5-11.
Konstantina Svokos and Leonard Goldstein; A discussion of the pathophysiology neuropathic pain and an overview of the modalities used to alleviate it; PPM 2011 December, 29 (9).
Pasero C. Pathophysiology of neuropathic pain. Pain Management Nursing. 2004 Dec 1;5:3-8.
Ushida T. Burdensome problems of chronic musculoskeletal pain and future prospects. Journal of Orthopaedic Science. 2015 Nov 1;20(6):958-66.
Mesci N, Mesci E, Külcü DG. Association of neuropathic pain with ultrasonographic measurements of femoral cartilage thickness and clinical parameters in patients with knee osteoarthritis. Journal of physical therapy science. 2016;28(8):2190-5.
Fernandes J, Kumar S. Occurrence of chemotherapy-induced peripheral neuropathy in cancer patients at Belagavi city: An observational study. Physiotherapy-The Journal of Indian Association of Physiotherapists. 2017 Jan 1;11(1):17.
Susan B. O’Sullivan, Thomas J. Schmitz, George D. Fulk; Physical Rehabilitation: Vascular, Lymphatic, and Integumentary Disorders; Ch 14, pg 577 - 644.
Published
PDF Downloads: 724
How to Cite
Issue
Section
Copyright © Author(s) retain the copyright of this article.